1. Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide;Caron;J Clin Endocrinol Metab,1997
2. Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly;Davies;Clin Endocrinol (Oxf),1998
3. Octreotide;Lamberts;N Engl J Med,1996
4. Octreotide long-acting release (LAR) a review of its use in management of acromegaly;McKeage;Drugs,2003
5. Somatostatin agonists for treatment of acromegaly;Ben-Shlomo;Mol Cell Endocrinol,2008